Suppr超能文献

肾动脉去神经术的长期效果。

Long-Term Effects of Renal Artery Denervation.

机构信息

Clinic of Heart and Vessel Diseases, Institute of Clinical Medicine at the Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania.

Center of Informatics and Development, Vilnius University Hospital Santaros Clinics, LT-08661 Vilnius, Lithuania.

出版信息

Medicina (Kaunas). 2021 Jun 27;57(7):662. doi: 10.3390/medicina57070662.

Abstract

: Renal artery denervation (RDN) procedure is a broadly discussed method in the treatment of resistant hypertension. Many studies report short-term (3-12 months) results for blood pressure and arterial stiffness. The primary endpoints were changes in 24 h mean systolic blood pressure (BP) and office systolic BP 48 months after RDN. The secondary endpoints were changes in aortic pulse wave velocity and impact of polypharmacy on these variables. : Renal artery denervation was performed in 73 patients treated for resistant hypertension; 49 patients remained in final analysis. Patient examination was carried out before the procedure, and subsequently at 3, 6, 12, 24, and 48 months later. Patients' antihypertensive and overall medication regimens were carefully analysed. : Mean 24 h arterial blood pressure lowered and was sustained at lower levels for up to 48 months; median (interequartile range-IQR) from 158(23.5)/100(14.2) to 140(26.5)/86(16.2) mmHg. Mean reduction in 24 h ambulatory systolic BP was -11 ± 25 mmHg (95% CI, -20 to -2; < 0.001), while office systolic BP reduced by -7 ± 23 mmHg (95%CI, -24 to -1; < 0.02). A significant reduction in median aortic pulse wave velocity 12 months after the procedure (drop from baseline 11.2 [3.15] m/s (95%CI 6.1 to 16.2) to 9.8 [2.1] m/s (95%CI 6.1 to 13.7; = 0.002)). After 48 months, there was no worsening compared to the baseline level of 10.3 [4.0] m/s (95% CI 6.9 to 17.8) ( > 0.05). The total mean number of antihypertensive drugs remained unchanged: 5.97(±1.1) vs. 5.24 (±1.45). A higher number of pills after 48 months was associated with higher aortic pulse wave velocity (1-5 pill group: 8.1 ± 1.6 m/s; 6-10 pill group: 10.9 ± 1.8 m/s; >11 pill group: 15.1 ± 2.6 m/s) ( = 0.003). : Antihypertensive effect after renal denervation lasts up to 48 months with no worsening of arterial stiffness compared to baseline. In our study, polypharmacy was associated with increased arterial stiffness 48 months after the procedure.

摘要

肾动脉去神经术(RDN)是治疗难治性高血压的一种广泛讨论的方法。许多研究报告了短期(3-12 个月)血压和动脉僵硬的结果。主要终点是 RDN 后 48 个月 24 小时平均收缩压(BP)和诊室收缩压的变化。次要终点是主动脉脉搏波速度的变化以及多药治疗对这些变量的影响。

在 73 名接受难治性高血压治疗的患者中进行了肾动脉去神经术;49 名患者进入最终分析。在手术前和随后的 3、6、12、24 和 48 个月后对患者进行检查。仔细分析了患者的降压和总体药物治疗方案。

24 小时动脉血压均值降低并持续在较低水平长达 48 个月;中位数(四分位距-IQR)从 158(23.5)/100(14.2)降至 140(26.5)/86(16.2)mmHg。24 小时动态收缩压平均降低-11 ± 25mmHg(95%CI,-20 至-2;<0.001),而诊室收缩压降低-7 ± 23mmHg(95%CI,-24 至-1;<0.02)。术后 12 个月主动脉脉搏波速度中位数显著降低(基线 11.2[3.15]m/s(95%CI 6.1 至 16.2)降至 9.8[2.1]m/s(95%CI 6.1 至 13.7;=0.002))。48 个月后,与基线水平 10.3[4.0]m/s(95%CI 6.9 至 17.8)相比,没有恶化(>0.05)。平均抗高血压药物总数保持不变:5.97(±1.1)vs.5.24(±1.45)。48 个月后服用更多药物与更高的主动脉脉搏波速度相关(1-5 片组:8.1±1.6m/s;6-10 片组:10.9±1.8m/s;>11 片组:15.1±2.6m/s)(=0.003)。

肾去神经术后的降压作用可持续长达 48 个月,与基线相比,动脉僵硬度无恶化。在我们的研究中,多药治疗与术后 48 个月时动脉僵硬的增加有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b1b/8305318/1056983323ba/medicina-57-00662-g001.jpg

相似文献

1
Long-Term Effects of Renal Artery Denervation.
Medicina (Kaunas). 2021 Jun 27;57(7):662. doi: 10.3390/medicina57070662.
3
Association between renal sympathetic denervation and arterial stiffness: the ASORAS study.
J Hypertens. 2023 Mar 1;41(3):476-485. doi: 10.1097/HJH.0000000000003361. Epub 2023 Jan 19.
4
Renal denervation in moderate treatment-resistant hypertension.
J Am Coll Cardiol. 2013 Nov 12;62(20):1880-6. doi: 10.1016/j.jacc.2013.06.023. Epub 2013 Jul 10.
5
Vascular and renal hemodynamic changes after renal denervation.
Clin J Am Soc Nephrol. 2013 Jul;8(7):1195-201. doi: 10.2215/CJN.08500812. Epub 2013 Apr 4.
9
Pulse Wave Velocity Predicts Response to Renal Denervation in Isolated Systolic Hypertension.
J Am Heart Assoc. 2017 May 17;6(5):e005879. doi: 10.1161/JAHA.117.005879.
10
Long-term follow-up of patients undergoing renal sympathetic denervation.
Clin Res Cardiol. 2022 Nov;111(11):1256-1268. doi: 10.1007/s00392-022-02056-5. Epub 2022 Jul 18.

引用本文的文献

1
Long-Term, Patient-Level Analysis of Radiofrequency Renal Denervation in the SYMPLICITY Clinical Trial Program.
JACC Adv. 2025 Mar;4(3):101606. doi: 10.1016/j.jacadv.2025.101606. Epub 2025 Feb 21.
3
The Efficacy of Renal Denervation in Treating Resistant Hypertension: A Systematic Review.
Cureus. 2024 Aug 16;16(8):e67007. doi: 10.7759/cureus.67007. eCollection 2024 Aug.
5
Effects of renal denervation on cardiac function after percutaneous coronary intervention in patients with acute myocardial infarction.
Heliyon. 2023 Jul 5;9(7):e17591. doi: 10.1016/j.heliyon.2023.e17591. eCollection 2023 Jul.
6
Renal denervation in patients with chronic kidney disease: current evidence and future perspectives.
Nephrol Dial Transplant. 2023 May 4;38(5):1089-1096. doi: 10.1093/ndt/gfac189.

本文引用的文献

1
Mechanisms of Arterial Stiffening: From Mechanotransduction to Epigenetics.
Arterioscler Thromb Vasc Biol. 2020 May;40(5):1055-1062. doi: 10.1161/ATVBAHA.119.313129. Epub 2020 Feb 20.
2
The Prevalence of Nonadherence in Patients With Resistant Hypertension: A Systematic Review Protocol.
Can J Kidney Health Dis. 2019 Dec 25;6:2054358119897196. doi: 10.1177/2054358119897196. eCollection 2019.
3
Renal denervation: Alternative treatment options for hypertension?
Prog Cardiovasc Dis. 2020 Jan-Feb;63(1):51-57. doi: 10.1016/j.pcad.2019.12.007. Epub 2019 Dec 27.
5
Effect of Catheter-Based Renal Denervation on Uncontrolled Hypertension: A Systematic Review and Meta-analysis.
Mayo Clin Proc. 2019 Sep;94(9):1695-1706. doi: 10.1016/j.mayocp.2019.07.005. Epub 2019 Aug 8.
6
Arterial Destiffening Starts Early after Renal Artery Denervation.
Int J Hypertens. 2019 Mar 3;2019:3845690. doi: 10.1155/2019/3845690. eCollection 2019.
7
Adherence in Hypertension.
Circ Res. 2019 Mar 29;124(7):1124-1140. doi: 10.1161/CIRCRESAHA.118.313220.
10
UHRF1 epigenetically orchestrates smooth muscle cell plasticity in arterial disease.
J Clin Invest. 2018 Jun 1;128(6):2473-2486. doi: 10.1172/JCI96121. Epub 2018 May 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验